Integrating ERM and Budget Formulation – 2021

View Session Recording

Speakers: Tanim Awwal, Dept. of Housing and Urban Development (HUD)
Emily M. Kornegay, HUD
Jonathan Lash, HUD
Sarah (SJ) Lynch, U.S. Food and Drug Administration (FDA)
Jen Wade, FDA
Moderator: Liz Ryan, Export-Import Bank

The FDA and HUD panelists will provide strategies and tactics that support risk-informed decision-making. Both agencies’ speakers will describe changes they have made to their FY 2023 Budget processes to better communicate on and manage enterprise risks. These include both tools and templates as well as ideas on relationships to make sure to foster.

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

Disclaimer of Warranty; Due Diligence. The resources and associated files are being offered "as is," and AFERM and the contributing authors disclaims all warranties of quality, whether express or implied, including the warranties of merchantability and fitness for particular purpose. The resource content recipient acknowledges that it has not been induced by any statements or representations of any person with respect to the quality or condition of the resource and associated files and that no such statements or representations have been made.

Limitation of Liability. Neither AFERM, its officers, directors, employees, agents, or contractors nor any contributing authors will be liable for any indirect, special, consequential, or punitive damages (including lost profits) arising out of or relating to these resources and associated files (whether for breach of contract, tort, negligence, or other form of action) and irrespective of whether the AFERM or the contributing authors have been advised of the possibility of any such damage.